Kezar Life Sciences, Inc. (KZR) Revenue History
Annual and quarterly revenue from 2016 to present
KZR Revenue Over Time (2016–2025)
KZR Revenue Growth History
0 of 1 years with positive growth- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- -100.0%
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | -100.0% |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
KZR Revenue Analysis (2016–2025)
Current Revenue & Growth
As of June 13, 2026, Kezar Life Sciences, Inc. (KZR) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
KZR's historical revenue data shows various trends over time. Kezar Life Sciences, Inc.'s highest annual revenue of $7.0 million was recorded in 2023.
Peer Comparison
Compared to Healthcare sector peers — including ARQT (+95.3% YoY), and TGTX (+81.3% YoY). Compare KZR vs ARQT →
KZR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 KZRCurrent | $0 | - | - | - | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 TGTX | $616M | +81.3% | +426.7% | 20.0% |
KZR Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-897,000 | - | $-52,270,000 | - |
| 2024 | $0 | -100.0% | $0 | - | $-90,605,000 | - |
| 2023 | $7.0M | - | $7.0M | 100.0% | $-111,424,000 | -1591.8% |
| 2022 | $0 | - | $0 | - | $-71,162,000 | - |
| 2021 | $0 | - | $-1,510,000 | - | $-54,659,000 | - |
| 2020 | $0 | - | $-1,544,000 | - | $-43,008,000 | - |
| 2019 | $0 | - | $-1,301,000 | - | $-37,977,000 | - |
| 2018 | $0 | - | $-690,000 | - | $-24,726,000 | - |
| 2017 | $0 | - | $-175,000 | - | $-8,749,000 | - |
| 2016 | $0 | - | $-154,000 | - | $-8,990,000 | - |
What if you invested $1,000 in KZR back in 2016?
Total return with dividends reinvested · 10+ years of data
Calculate ReturnsHow much would $100/month in KZR be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs KZR Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationKZR vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowKZR — Frequently Asked Questions
Quick answers to the most common questions about buying KZR stock.
Is KZR's revenue growth accelerating or slowing?
KZR TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is KZR's revenue history from 2016 to 2026?
Kezar Life Sciences, Inc. (KZR) revenue history spans 2016 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is KZR's long-term revenue growth rate (CAGR)?
Kezar Life Sciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for KZR.
Why does KZR's quarterly revenue fluctuate?
KZR quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Kezar Life Sciences, Inc.'s revenue data from 2016 to 2026 shows full historical quarterly detail on this page.
How is KZR's revenue distributed by segment?
KZR reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does KZR's revenue compare to industry peers?
Kezar Life Sciences, Inc. (KZR) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.